Citi Pharma Limited and CCL Pharma (Pvt) Limited have executed an agreement to manufacture Formulation Products on their behalf. This will lead to enhanced capacity utilization in the Company;s Formulation segment.
Moreover, this will lead to addition in the Company’s profitability and net margins over the next 2 to 3 years.